ulcerative colitis: latest news - GoINPHARMA
Tuesday, 18 September 2018 - 21:15

Ulcerative colitis

AstraZeneca, agreement with Allergan for inflammatory diseases

AstraZeneca today announced that MedImmune, its R&D arm, has signed a licensing agreement with Allergan for the global rights to MEDI2070, an IL-23 monoclonal antibody currently in a Phase IIb clinical trial. The ongoing trial has been designed to evaluate…

Gilead discontinues trials for ulcerative colitis drug

Gilead Sciences has announced the decision to terminate its Phase 2/3 clinical trial designed to evaluate GS-5745 among patients with moderately to severely active ulcerative colitis. GS-5745 is an anti-MMP9 monoclonal antibody. This decision follows the results of a planned…